Event

Sophia Wang

MD
China Novartis Institutes for Biomedical Research Co., Ltd.

Robert Fogel

MD
Novartis Pharmaceuticals Corporation

Nanshan Zhong

MD, FCCP
Guangzhou Medical University;National Clinical Research Centre for Respiratory Diseases, First Affiliated Hospital of Guangzhou M;State Key Lab of Respiratory Disease, National Clinical Research Cente

Jing Li

PhD
Guangzhou Medical University

Ioannis Kottakis

MD
Novartis Pharma AG

Michael Humphries

MD
Beijing Novartis Pharma Co. Ltd.

Chang Zheng Wang

MD
Xingqiao Hospital, Third Military Medical University

Jian Kang

PhD
First Hospital of China Medical University;Institute of Respiratory Disease, First Hospital of China Medical University

Jing Yang

MD
Beijing Novartis Pharma Co. Ltd.

Zi Lin

MD
Beijing Novartis Pharma Co. Ltd.

Serum IgE Levels as Predictor for Treatment Outcomes in Chinese Patients with Moderate or Severe Allergic Asthma Treated with Omalizumab